Correction to Multidisciplinary diabetes care with and without bariatric surgery in overweight people: A randomised controlled trial [Lancet Diabetes Endocrinol, 2014], Doi: 10.1016/S2213-8587(14)70066-X;Multidisciplinary diabetes care with and without bariatric surgery in overweight people: A randomised controlled trial

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 7, 2014, Pages 545-552

  Wentworth, John M ^a,b   Playfair, Julie ^a   Laurie, Cheryl ^a   Ritchie, Matthew E ^b   Brown, Wendy A ^a   Burton, Paul ^a   Shaw, Jonathan E ^c   O'Brien, Paul E ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; EXENDIN 4; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; METFORMIN; SITAGLIPTIN; SULFONYLUREA DERIVATIVE; TRIACYLGLYCEROL; ANTIDIABETIC AGENT;

ADULT; ARTICLE; AUSTRALIA; BARIATRIC SURGERY; BLOOD PRESSURE; CALORIC RESTRICTION; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DYSGLYCEMIA; FEMALE; GASTRIC BANDING; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDISCIPLINARY DIABETES CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITIONAL INTOLERANCE; OBESITY; OPEN STUDY; PARALLEL DESIGN; PATIENT CARE; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REMISSION; REOPERATION; SELF CARE; WEIGHT REDUCTION; ADOLESCENT; AGED; COMPLICATION; DIABETES MELLITUS, TYPE 2; GASTROPLASTY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; COMBINED MODALITY THERAPY; DIABETES MELLITUS, TYPE 2; FEMALE; GASTROPLASTY; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; OVERWEIGHT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84903783176     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70038-5     Document Type: Erratum

References (29)

1. Zimmet P, Alberti KG, Shaw J Global and societal implications of the diabetes epidemic. Nature 2001, 414:782-787.
2. Standards of medical care in diabetes-2013. Diabetes Care 2013, 36(suppl 1):S11-S66. American Diabetes Association.
3. Gregg EW, Chen H, Wagenknecht LE, et al. Association of an intensive lifestyle intervention with remission of type 2 diabetes. JAMA 2012, 308:2489-2496.
4. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008, 299:316-323.
5. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012, 366:1577-1585.
6. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012, 366:1567-1576.
7. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial. JAMA 2013, 309:2240-2249.
8. Astiarraga B, Gastaldelli A, Muscelli E, et al. Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab 2013, 98:2765-2773.
9. DePaula AL, Macedo AL, Mota BR, Schraibman V Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29. Surg Endosc 2009, 23:1313-1320.
10. Ferzli GS, Dominique E, Ciaglia M, Bluth MH, Gonzalez A, Fingerhut A Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis. World J Surg 2009, 33:972-979.
11. Geloneze B, Geloneze SR, Fiori C, et al. Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion. Obes Surg 2009, 19:1077-1083.
12. Klein S, Fabbrini E, Patterson BW, et al. Moderate effect of duodenal-jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes. Obesity 2012, 20:1266-1272.
13. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med 2009, 361:445-454. The Longitudinal Assessment of Bariatric Surgery (LABS) Consortium.
14. Cobourn C, Mumford D, Chapman MA, Wells L Laparoscopic gastric banding is safe in outpatient surgical centers. Obes Surg 2010, 20:415-422.
15. O'Brien P, McDonald L, Anderson M, Brennan L, Brown WA Long term outcomes after bariatric surgery: Fifteen year follow up after gastric banding and a systematic review of the literature. Ann Surg 2013, 257:87-94.
16. Standards of medical care in diabetes-2009. Diabetes Care 2009, 32(suppl 1):S13-S61. American Diabetes Association.
17. O'Brien PE The lap-band solution. A partnership for weight loss 2011, Melbourne University Press, Melbourne.
18. Ware JE SF-36 health survey update. Spine 2000, 25:3130-3139.
19. Dixon JB, Chuang LM, Chong K, et al. Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes. Diabetes care 2013, 36:20-26.
20. Jurowich C, Thalheimer A, Hartmann D, et al. Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery-who fails in the early postoperative course?. Obes Surg 2012, 22:1521-1526.
21. Ramos-Levi AM, Matia P, Cabrerizo L, et al. Statistical models to predict type 2 diabetes remission after bariatric surgery. J Diabetes 2014, published online Feb 26. 10.1111/1753-0407.12127.
22. Look ARG, Wing RR, Bolin P, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013, 369:145-154.
23. Dixon JB, Zimmet P, Alberti KG, Rubino F Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med 2011, 28:628-642. International Diabetes Federation Taskforce on E, PreventionPrevention.
24. Gaede P, Lund-Andersen H, Parving HH, Pedersen O Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
25. Colagiuri S, Diabetes Australia, Eli Lilly Australia, Medical Technology Assessment Group (M-TAG). DiabCot Australia: assessing the burden of type 2 diabetes in Australia: Australian Centre for Diabetes Strategies, 2002.
26. Keating CL, Dixon JB, Moodie ML, Peeters A, Playfair J, O'Brien PE Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial. Diabet Care 2009, 32:580-584.
27. Keating CL, Dixon JB, Moodie ML, et al. Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis. Diabetes Care 2009, 32:567-574.
28. Himpens J, Cadiere GB, Bazi M, Vouche M, Cadiere B, Dapri G Long-term outcomes of laparoscopic adjustable gastric banding. Arch Surg 2011, 146:802-807.
29. Buchwald H, Oien DM Metabolic/bariatric surgery worldwide 2011. Obes Surg 2013, 23:427-436.